top of page

UTHR

United Therapeutics

Price

chg

chg neg

quotes and stock data may be delayed 15 minutes

 My Notes

Only BPIQ Pro members can create company notes. Learn more here.

52 wk low

low api

52 wk hi

high api

Cash

$2.27B

Burn Rate (Qtr)

N/A

Mkt Cap

mkt cap api

Avg Volume

volume api

*cash/burn updated:

Q1 '22

Drug Pipeline

Click the button to see the updated pipeline

No drug found

We don't have any drug data for this company yet

Drug | Disease (links)

Stage (next event)

Catalyst Date

Drug Name

Indication

Phase

Event

Exp Date

A free account is required to see the catalyst dates, notes, and more!

Loading Catalysts...

search in progress

Pipeline powered by

UTHR

BPIQ_Logo_RGB-01.jpg

Company Profile

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. We currently have five approved products on the market, and a long-term mission of providing an unlimited supply of transplantable organs for those who need them! Our employees can be found collaborating across the United States, Europe and Asia. As a group, we are relentless in our pursuit of “medicines for life” and continue to research and develop treatments for cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases.

Recent Posts

See what the community is saying - click to see full post.

How Did Q1 Hedge Fund Top 20 Returns Compare to Other Quarters?

J.P. Morgan 2023 Healthcare Conference

Q1 '22 Perceptive Closed Positions (hedge fund)

Biotech PDUFAs to Watch October 2021 - AVDL CCXI CSLD

bottom of page